NCT07053852 - Activation of Ameluz With BBL HEROic for the Treatment of Actinic Keratoses and Photodamage | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 27, 2025

Primary Completion Date

December 1, 2025

Study Completion Date

February 1, 2026

Conditions

Actinic KeratosesPhotodamage

Interventions

DRUG

Ameluz

broad band light (BBL) with the use of Ameluz

DEVICE

Sciton HEROic

Each subject will receive 2 treatments of photodynamic therapy using Ameluz and HEROic BBL to treat facial AK and signs of photodamage.

Trial Locations (1)

RECRUITING

Rochester Dermatologic Surgery, Victor